Table 1. Minimum inhibitory concentrations (μg/ml) of Products A, B, C and commercial topical ophthalmic products against bacterial isolates.

	MICs of the tested preparation in μg/ml.
Strain	A	B	C	Tobramycin	Gentamicin	Ofloxacin
Moraxella bovis 80–2013000742	0.78	≥ 6.25	≥ 1500	≤ 0.36	≤ 0.36	≤ 0.36
Moraxella bovis 36–2012001922	6.25	6.25	≥ 1500	≤ 0.36	≤ 0.36	≤ 0.36
Moraxella bovis 120–2014002878	6.25	≥ 6.25	≥ 1500	≤ 0.36	≤ 0.36	≤ 0.36
Moraxella bovis 42–2012003587	6.25	≥ 6.25	≥ 1500	≤ 0.36	≤ 0.36	≤ 0.36
Neisseria spp. isolate 1	6.25	6.25	≥ 1500	≤ 11.7	≤ 11.7	≤ 11.7
Pseudomonas aeruginosa 15442	6.25	6.25	≥ 1500	≤ 0.36	0.73	0.73
Pseudomonas aeruginosa isolate 1	6.25	6.25	≥ 1500	≤ 0.36	≤ 0.36	≤ 0.36
Pseudomonas aeruginosa isolate 2	25	6.25	≥ 1500	≤ 0.36	≤ 0.36	5.8
Staphylococcus aureus isolate 1	6.25	6.25	≥ 1500	≤ 0.36	≤ 0.36	≤ 0.36
Staphylococcus aureus isolate 2	6.25	6.25	≥ 1500	0.73	0.73	≤ 0.36
Staphylococcus pseudintermedius Case one	3.13	6.25	≥ 1500	11.7	23.4	23.4
Staphylococcus pseudintermedius Case two	3.13	3.13	≥ 1500	≤ 11.7	≤ 0.391	≤ 0.391
Streptococcus canis isolate 1	12.5	≥ 6.25	≥ 1500	5.8	2.9	0.73
Streptococcus canis isolate 2	12.5	≥ 6.25	≥ 1500	11.7	5.8	0.73
Streptococcus canis isolate 3	12.5	6.25	≥ 1500	5.9	2.9	1.5
Streptococcus canis isolate 4	6.25	≥ 6.25	≥ 1500	11.7	5.8	0.73
Streptococcus schleiferi isolate 1	0.78	≥ 6.25	≥ 1500	≤ 0.36	≤ 0.36	≤ 0.36

All MIC values are recorded in μg/ml. Concentrations were calculated from the dilutions of the active ingredient in each of the original commercially available products.